Due to the delays in activating new clinical sites, Talphera now anticipates study completion in the first half of 2026, moving back from its previous expectation of year-end 2025. The company is ...

Fred Earnest, President and CEO, highlighted progress on the 15,000 ton per day Mt Todd feasibility study, which remains on schedule for completion by mid-2025. Management is targeting a 60% reduction ...

Abbvie (ABBV) announced an update on their ongoing clinical study. AbbVie has recently completed a clinical study titled ‘Venetoclax (Venclexta Tablet) Post-Marketing Surveillance for CLL Patients.’ ...

AUSTIN, Texas, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company, today announced the completion of drug administration in an open-label ...

– Study P01 is the first of two studies as agreed with the EMA in the Company’s Pediatric Investigation Plan for macimorelin as a growth hormone deficiency diagnostic – Dr. Nicola Ammer, Chief Medical ...

A much ballyhooed economic development study that will chart the Pikes Peak region’s future jobs-generating strategy, and which was supposed to be completed three months ago, is nearing completion, ...